1-10 of 10 results for subject:MRSA
Librarians' tools
- Search time
- 0.212 seconds
- Solr query time
- 0.004 seconds
- Search query
- subject:MRSA
- We searched for
- subject_t:MRSA OR subject_t:"Methicillin resistant staphylococcus aureus" OR subject_ses:11632
Answering member
X
Simon Burns
Type
House
Session
Year
Department
Member
Primary member
Answering member
More
Burns, Simon (10)
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health what steps are being taken to protect public health from methicillin-resistant Staphylococcus aureus.
To ask the Secretary of State for Health what steps are being taken to protect public health from methicillin-resistant Staphylococcus aureus.
Asked by
Andrew Rosindell
(Conservative)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2011
For answer on
24 November 2011
Answered on
29 November 2011
The Government continue to encourage the national health service to operate a zero tolerance approach to all avoidable methicillin- resistant Staphylococcus aureus (MRSA) bloodstream infections.The NHS Operating Framework 2012-13 (published 24 November 2011) includes a MRSA objective which will require those organisations who have the highest rates of MRSA bloodstream infections to make the largest reductions.In this way we will continue to build on the significant progress already made by the NHS and move the performance of all organisations towards the level of the best and, consequently reduce infection rates further.
Subjects
MRSA
Date
29 November 2011
Reference
83126; 536 c878W
House
House of Commons
To ask the Secretary of State for Health what assessment he has made of the capacity of methods of screening against the MRSA bacterium used by NHS hospitals to detect new strains of the infection; and if he will make a statement.
To ask the Secretary of State for Health what assessment he has made of the capacity of methods of screening against the MRSA bacterium used by NHS hospitals to detect new strains of the infection; and if he will make a statement.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 February 2011
For answer on
28 February 2011
Answered on
2 March 2011
Many laboratory methods are available to national health service hospitals to detect Methicillin-resistant Staphylococcus aureus (MRSA) and these meet the European Commission standards for safety, quality and performance. NHS trust laboratories use simple tests to detect MRSA. These tests have been available for many years and are capable of detecting the emergence of a new MRSA on this basis.
Subjects
MRSA; Screening
Date
2 March 2011
Reference
42983; 524 c496W
House
House of Commons
To ask the Secretary of State for Health what progress has been made on licensing for use in the NHS of the Defence Science and Technology Laboratory's product BacLite to screen against the MRSA bacterium.
To ask the Secretary of State for Health what progress has been made on licensing for use in the NHS of the Defence Science and Technology Laboratory's product BacLite to screen against the MRSA bacterium.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 February 2011
For answer on
28 February 2011
Answered on
1 March 2011
Any diagnostic test of this type should be CE marked by the manufacturer according to the safety, quality and performance requirements of the In Vitro Diagnostic Devices Directive (transposed in to United Kingdom law by the Medical Devices Regulations 2002) before they are placed on the UK market. Under the directive, national regulatory authorities, who in the UK are the Medicines and Healthcare products Regulatory Agency, are not directly involved in the pre-market conformity assessment process for such tests and therefore hold no information on the product's current approval status.
Subjects
MRSA; Screening
Date
1 March 2011
Reference
42876; 524 c383W
House
House of Commons
To ask the Secretary of State for Health what steps he is taking to improve methods of screening against the MRSA bacterium; and if he will make a statement.
To ask the Secretary of State for Health what steps he is taking to improve methods of screening against the MRSA bacterium; and if he will make a statement.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 February 2011
For answer on
28 February 2011
Answered on
1 March 2011
A variety of methods are available to national health service trusts to screen against Methicillin-resistant Staphylococcus aureus. Individual trusts make their own decisions on which tests or combinations of tests to use depending on their clinical case mix and workload. The local clinical need will determine test selection. Rapid and more sensitive methods have been available to the NHS for a number of years and trusts make their own decisions on matching the technologies to their service needs.In 2004, as part of the Department's commitment to ensuring the NHS has access to effective infection prevention and control technologies, it has asked the Health Protection Agency to convene the Rapid Review Panel (RRP). This provides a prompt assessment of new and novel equipment, materials and other products or protocols that may be of value to the NHS and social care in the prevention and control of hospital associated infections.
Subjects
MRSA; Screening
Date
1 March 2011
Reference
42984; 524 c383W
House
House of Commons
To ask the Secretary of State for Health what methods of screening against the MRSA bacterium hospitals use; what assessment he has made of the effectiveness of such methods; and if he will make a statement.
To ask the Secretary of State for Health what methods of screening against the MRSA bacterium hospitals use; what assessment he has made of the effectiveness of such methods; and if he will make a statement.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 February 2011
For answer on
28 February 2011
Answered on
28 February 2011
There are four types of suitable Meticillin resistant Staphylococcus aureus (MRSA) screening methods. These are:"1. Polymerase Chain Reaction (PCR test) of nucleic acids (rapid testing);""2. Rapid enrichment and immunomagnetic/bioluminescent detection;""3. Chromogenic Agar plating (direct culture); and""4. Broth enrichment culture followed by agar subculture."Decisions regarding what type of test to use either in isolation or combination are made locally based on clinical protocols. The Department has not conducted an assessment of the effectiveness of the different screening methods.Diagnostic MRSA screening tests for any of these types should be CE marked by the manufacturer according to the safety, quality and performance requirements of the EC in vitro diagnostic devices directive (transposed in to United Kingdom law by the Medical Devices Regulations 2002) before they are placed on the UK market.
Subjects
MRSA; Screening
Date
28 February 2011
Reference
43012; 524 c135-6W
House
House of Commons
To ask the Secretary of State for Health how many cases of MRSA infection were identified in NHS facilities in 2010.
To ask the Secretary of State for Health how many cases of MRSA infection were identified in NHS facilities in 2010.
Asked by
Mike Weatherley
(Conservative)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
24 January 2011
For answer on
26 January 2011
Answered on
31 January 2011
There is currently published data available for the first 11 months of 2010, providing details of the number of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemias (bloodstream infections). A full year's data for 2010 will be available when data for December 2010 are published on 2 February 2010.Published monthly data indicate that between January 2010 and November 2010 there were a total of 1,514 MRSA bacteraemias reported by acute national health service trusts in England. Of this number, 766 were apportioned to acute trusts."Notes:""1. All acute trusts in England are obliged to report all cases of MRSA bloodstream infection to the Health Protection Agency (HPA). Data on other MRSA infections, that did not enter the bloodstream, are not included as they are not part of this mandatory surveillance system.""2. Trusts report all cases for which their laboratories process the specimens. This may not always reflect where the infection was acquired.""3. MRSA bacteraemias are considered to be "trust apportioned' cases if they meet all of these three criterion:""the location where the specimen was taken is "acute trust' or is not known;""the patient is an in-patient, emergency assessment, or is not known; and""the date that the specimen was taken was on or after day three of admission to hospital (where the day of admission is day one)."
Subjects
MRSA
Date
31 January 2011
Reference
36435; 522 c636W
House
House of Commons
To ask the Secretary of State for Health what steps he is taking to reduce the number of cases of MRSA.
To ask the Secretary of State for Health what steps he is taking to reduce the number of cases of MRSA.
Asked by
Mike Weatherley
(Conservative)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
20 January 2011
For answer on
24 January 2011
Answered on
26 January 2011
Although the national health service has made significant reductions in the number of Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemias (bloodstream infections), this Government are determined to do all they can to support the health and adult social care providers to make further improvements. From the outset, through the coalition agreement, this Government made clear that they expected the NHS to adopt a zero tolerance approach to all health care associated infections (HCAIs), including MRSA.The ““NHS Operating Framework 2011-12””, published in December, requires the NHS to continue prioritising the achievement of the MRSA Objective, as well as the new Clostridium difficile (C. difficile) Objective. These Objectives, through their successful implementation, will have a significant impact on reducing variation by moving all organisations towards the performance of the best and consequently will at the same time reduce numbers at a national level.We have also, from the end of December 2010, extended the previous requirement for the NHS to screen all relevant elective admissions to also include relevant emergency admissions.To support the wide availability of data to help drive further reductions in MRSA, we have introduced weekly publications of data for both MRSA bloodstream infections and C. difficile infections at hospital-site level.We are also committed to ensuring that the NHS continue to have access to evidence-based guidance in order to reduce the number of all HCAIs, including MRSA, through the implementation of effective infection prevention and control practices. As part of this commitment, a comprehensive suite of updated guidance was published on the Department's ““Clean, Safe Care”” website on 6 January 2011.The Health and Social Care Act 2008 ““Code of Practice for health and adult social care on the Prevention and Control of Infections and related guidance””, which the Care Quality Commission use as a basis for assessing compliance with the registration requirement on cleanliness and infection control, has been a driver for improvement in the hospital setting. We extended the scope of the Code to adult social care settings from October 2010 and will include primary care in due course so that we can ensure that all settings where patients receive care and treatment operate comparable infection prevention and control practices.
Subjects
MRSA
Date
26 January 2011
Reference
36067; 522 c375-6W
House
House of Commons
To ask the Secretary of State for Health what steps his Department is taking to reduce the incidence of MRSA.
To ask the Secretary of State for Health what steps his Department is taking to reduce the incidence of MRSA.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
1 December 2010
This Government are determined to do all they can to support the health and adult social care providers reduce Methicillin-resistant Staphylococcus aureus (MRSA). From the outset, through the Coalition Agreement, this Government made clear that they expected the national health service to adopt a zero tolerance approach to all health care associated infections (HCAIs), including MRSA.In the revision of the 2010-11 Operating Framework published in June, it was made clear that the NHS should continue prioritising the achievement of the MRSA objective. The successful implementation of this objective will deliver both an overall reduction nationally and, importantly, will reduce variation by moving all organisations towards the performance of the best.At the same time, the revision of the Operating Framework confirmed that it expected and required the NHS to implement MRSA screening of all relevant emergency admissions by the end of this year.[n terms of using the availability of data as a driver to supporting further reductions in MRSA, we have introduced weekly data publication of both MRSA blood stream infections and Clostridium difficile infections at hospital site level.We are also committed to ensuring that the NHS continue to have access to evidence based guidance in order that they can reduce the number of all HCAIs, including MRSA, through the implementation of effective infection prevention and control practices. This guidance is available on the Department of Health's ““Clean, Safe Care”” website.The Health and Social Care Act 2008 ““Code of Practice for health and adult social care on the Prevention and Control of Infections and related guidance””, which the Care Quality Commission use as a basis for assessing compliance with the registration requirement on cleanliness and infection control has been a driver for improvement in the hospital setting. The scope of the Code has already been extended to adult social care settings and will include primary care in due course so that we can ensure that all settings where patients receive care and treatment operate comparable infection prevention and control practices.
Subjects
MRSA; Screening
Date
1 December 2010
Reference
26392; 519 c899-900W
House
House of Commons
To ask the Secretary of State for Health what progress has been made towards meeting his Department's 2011 deadline for the screening of non-elective patients for MRSA.
To ask the Secretary of State for Health what progress has been made towards meeting his Department's 2011 deadline for the screening of non-elective patients for MRSA.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
1 December 2010
As outlined in the ““NHS Operating Framework 2010/11””, there is a requirement to introduce Methicillin-resistant Staphylococcus aureus screening. Good progress is being made by organisations to implement screening for this cohort of patients, with some organisations already having declared full implementation of the policy and all organisations planning to implement emergency screening for relevant emergency admissions within the expected time scale. Strategic health authorities will continue to monitor delivery towards the requirement by 31 December 2010.
Subjects
MRSA; Screening
Date
1 December 2010
Reference
26390; 519 c899W
House
House of Commons
To ask the Secretary of State for Health what information his Department collates for the purpose of monitoring rates of MRSA.
To ask the Secretary of State for Health what information his Department collates for the purpose of monitoring rates of MRSA.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
1 December 2010
Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia are subject to mandatory reporting to the Health Protection Agency. The Department uses the outputs from this system to assess and monitor rates of MRSA bacteraemia at both national and local levels.
Subjects
MRSA; Screening
Date
1 December 2010
Reference
26391; 519 c900W
House
House of Commons